While biotechnology has met with mixed public reactions, to date nanotechnology seems to invoke much less public concern.

Some forms of biotechnology have become notoriously controversial. Genetic modification of crops, for example, altered the food supply in ways some consumers found troublesome, either because of anticipated consequences, a lack of tangible benefit, lack of opportunity to participate in the decision-making, or simply a sense of inherent “unnaturalness.” Stem cell research has raised similar uneasiness, albeit for entirely different reasons, largely moral beliefs that equate it with the destruction of human embryos. So far, though, public perception of nanotechnology does not seem to be headed in the same direction. Sure, there are appeals for regulation and isolated protests, but it doesn’t seem as though there is really as much in the way of concerted will behind them. While some might be waiting for the other shoe to drop—I’ve been told many times that public concerns about nano are bound to emerge “just as soon as people understand what this is all about”—events so far suggest it may be a long wait.

Despite emerging evidence of potential toxicity to human health and the environment from some forms of nanotechnology under some circumstances, not much popular alarm has arisen. Great uncertainty remains over which products and under what circumstances we should be concerned, but of course this hasn’t stopped public reaction in the past. Several potential “triggering events” of the sort we social scientists might have expected would unleash underlying fears have already happened. In 2006, reports emerged of serious respiratory problems among German consumers using a household cleaning product called “Magic Nano,” and evidence published in 2009 indicated severe lung disease and even deaths among a small group of Chinese factory workers exposed to nanoparticles (and many other chemicals, as it turns out). In both cases, the link between nanotechnology and disease is far from clear. “Magic Nano” may not even have contained nanoparticles; the label was apparently chosen in an attempt to hype the product, much like the name “iPod nano.” Clearly, the marketers involved believed the word “nano” is attractive to consumers, rather than a source of concern for them.

To me, as a social scientist who studies risk communication, perception and reality are indeed the same thing, and so the interesting question is why, when uncertainty about risks has certainly not stopped public opinion from turning sour in the past, should nano be getting the benefit of the doubt while so much of bio remains persistently controversial?

The answer may lie in the nature of our technoscientific culture. I recently published a multi-year panel study involving 76 citizens of South Carolina, representing various walks of life, which reinforced the notion that because most Americans like technology, they are generally willing to give nanotechnology a pass, at least for now, even though they don’t know much about it. About two-thirds of the panel held positive views, and the negative minority seemed to draw on negative expectations about technology more generally, rather than specific views about nanotechnology. Panelists’ views changed little over the 32 months of the study. The most common concerns, reasonably enough, centered on unexpected consequences and unanticipated side effects. Indeed, people seemed perfectly aware of the uncertainties surrounding nano-associated risks, but this hardly appeared to induce fear.

To those of us who lived through the early years of the genetically modified (GM) food “wars,” which some tended to attribute to a lack of familiarity alongside low levels of trust, this is pretty interesting. Nano involves many of the same sorts of key actors (major corporations, government regulators, scientists, engineers, and consumer advocacy groups) and, if anything, even greater levels of scientific uncertainty. Yet there’s something quite different about what we call the “climate of public opinion” for nanotechnology as opposed to biotechnology, particularly GM. To be sure, some observers are invoking the so-called precautionary principle (the largely European idea that we should not adopt a technology until the evidence shows it does not cause harm), but even in such cases it usually seems that they are calling for precaution because they think this is generally the right way to manage any new technology, rather than because nanotechnology is particularly worrisome.

So what makes nano so different from bio? Simply put, manipulating DNA simply seems to challenge our underlying cultural ideas about how the world ought to be in ways that manipulating otherwise ordinary materials does not.

For those who want to communicate about risk in a responsible way with the so-called “lay” or non-specialist public, nano represents a novel challenge. Rather than being an “amplified” risk, by which I mean one that the media and other social institutions have tended to highlight, nanotechnology may represent an “attenuated” risk, or one that these institutions have tended to ignore. If people are too fearful of a technology, they may lose out on its potential benefits, yet if too trusting, they may ignore important risks. But few among us really want to be the one yelling “Fire!” in a crowded world. After all, we’re still not even sure there’s a problem. Are we?

Indeed, just last month (January 25), the National Research Council issued a report calling for a coordinated research plan to investigate nanotechnology’s poorly understood risks to both health and environment, lest its beneficial promise for society ultimately go unrealized.

Susanna Priest (susannapriest@yahoo.com) is the author of Nanotechnology and the Public: Risk Perception and Risk Communication (Taylor and Francis, 2012), as well as a November 2011 article in Risk Analysis (Volume 31, Issue 11, pp. 1718-1733) on “Envisioning Emerging Technologies,” which reports on the panel study results as part of a special issue. She also edits the academic journal Science Communication.

More here:
Opinion: No Objections to Nano?

www.youtube.com/watch?v=uSHLqowYqjU

Continue reading here:
Ross Nanotechnology Introduction.flv – Video

Here is the original post:
Nanotechnology scientist left US job to fight Maharashtra local polls

Link:
Research and Markets: Smart Materials and Nanotechnology in Engineering: An Eminently up-to-Date Guide

NEW YORK, February 1, 2012 /PRNewswire/ —

New Report Added in ResearchMoz Reports Database Nanotechnology in Drug Delivery: Global Markets

The report provides an in-depth presentation of recent developments (2000-2010) in nanoparticle-enabled DDS and future opportunities (2011-2021).  Persons with a financial or academic interest in the pharmaceutical industry who want to learn how advances in nanotechnology research and development will impact the economics of the pharmaceutical market will benefit most from this report.

Browse the full Report:  http://www.researchmoz.com/nanotechnology-in-drug-delivery-global-markets-report.html 

This report will focus on a geographical breakdown of the developed NDD TAM for the period 2000-2010, with a forecast NDD TAM for the period 2011-2021. The values are presented in $USD as well as percentages.

In the decade since the international spotlight focused on nanotechnology, with some predicting a trillion dollar nanotech-enabled market by 2020, it has become increasingly clear from which areas of science and industry that market will materialise. Cientifica's Global Funding of Nanotechnologies 2011 tracked the growth of government funding to a total of $67.5 billion from 2000 to 2011.

Nanotechnology in Drug Delivery: Global Markets, indicates nanotech-enabled drug delivery therapeutics is set to grow from a current value of $2.3 billion to $136 billion by the year 2021. This sector will therefore represent approximately 15% of the global nanotechnology market in 2021. Healthcare offers the greatest opportunity to add value to nanomaterials and China is the fastest-growing market sector.

Cientifica's research indicates that global growth in the drug delivery market will be led by Asia with a compound annual growth rate (CAGR) of 32.5% between now and 2021. China will be the largest market for nanotechnology based drug delivery systems by 2021, worth more than $18 billion  and representing 43% of the Asian market.

France is forecast to surpass Japan as a drug delivery market within 10 years. Among European Union countries, the highest growth will be found in the former Eastern Bloc, and the lowest in the UK.

Browse All Pharmaceutical Market Research Reports & Industry Analysis

Browse All Cientifica Research Reports & Industry Analysis

Browse All  Nanotechnology Market  Research Reports

Nanotechnology in Drug Delivery

Mid Infrared (IR) Sensors Market

Energy Harvesting Market

Nanotechnology in Drug Delivery 2011-2021

Role of Nanotechnology in the Energy Industry

World Market for Nanotechnology: Applications, Markets and Companies,The

Nanotechnology And Nanomaterials In The Electronics Sector

Nanotechnology And Photovoltaics: Market, Companies And Products

Nanotechnology And Nanomaterials In The Automotive Industry

Nanotechnology in Drug Delivery – Technological Improvements and Novel Approaches to Fulfill High Potential

Direct Methanol Fuel Cell (DMFC) Market

Flexible Glass Market

Global Funding of Nanotechnologies – 2011 Edition

About Us

ResearchMoz is the one stop online destination to find and buy market research reports. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email:  sales@researchmoz.com
http://www.researchmoz.com/
http://www.marketresearchreportsblog.com/ 
http://www.wpt9.com/
http://www.latestmarketreports.com/ 

Visit link:
ResearchMoz: Nanotech Enabled Drug Delivery Therapeutics Market Will be $136 Billion by the Year 2021: Nanotechnology …

Follow this link:
Cambrios Technologies Enters Strategic Growth Phase with New CEO, John LeMoncheck, and New Funding from Samsung …

NEW YORK, Jan. 31, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:

Nanotechnology in Drug Delivery: Global Markets,

http://www.reportlinker.com/p0766029/Nanotechnology-in-Drug-Delivery-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

The report provides an in-depth presentation of recent developments (2000-2010) in nanoparticle-enabled DDS and future opportunities (2011-2021). Persons with a financial or academic interest in the pharmaceutical industry who want to learn how advances in nanotechnology research and development will impact the economics of the pharmaceutical market will benefit most from this report.

This report will focus on a geographical breakdown of the developed NDD TAM for the period 2000-2010, with a forecast NDD TAM for the period 2011-2021. The values are presented in $USD as well as percentages.

In the decade since the international spotlight focused on nanotechnology, with some predicting a trillion dollar nanotech-enabled market by 2020, it has become increasingly clear from which areas of science and industry that market will materialise. Cientifica's Global Funding of Nanotechnologies 2011 tracked the growth of government funding to a total of $67.5 billion from 2000 to 2011.

Nanotechnology in Drug Delivery: Global Markets, indicates nanotech-enabled drug delivery therapeutics is set to grow from a current value of $2.3 billion to $136 billion by the year 2021. This sector will therefore represent approximately 15% of the global nanotechnology market in 2021. Healthcare offers the greatest opportunity to add value to nanomaterials and China is the fastest-growing market sector.

Cientifica's research indicates that global growth in the drug delivery market will be led by Asia with a compound annual growth rate (CAGR) of 32.5% between now and 2021. China will be the largest market for nanotechnology based drug delivery systems by 2021, worth more than $18 billion and representing 43% of the Asian market.

France is forecast to surpass Japan as a drug delivery market within 10 years. Among European Union countries, the highest growth will be found in the former Eastern Bloc, and the lowest in the UK.

Table of ContentsExecutive Summary

Chapter 1

• Report Scope

• Thematic Scope

• Scope of Data Analysis

• Temporal Scope of Analysis

• Geographical Scope

• Report objective

• Methodology

• Calculation of CAGR

• The Nanoscale

Chapter 2

• Overview of nanotechnology

• What are the Key Drivers for Adoption of Nanotechnology in Medicine and Biomedicine?

• The Key Applications of Nanotechnology in Medicine and Biomedicine

• How Nanotechnology Can Benefit Drug Delivery

• How Nanotechnology Is Already Having An Impact On The Drug Delivery Sector

Chapter 3

• Three Key Barriers to The Adoption of Nanotechnology in Medicine and Biomedicine

• Five Current & Future Challenges in The Adoption of Nanotechnology in Medicine and Biomedicine

Chapter 4

• Global Market Analysis: 2000-2010 (Without Segmentation)

• Global Market Forecast: 2011-2021 (Without Segmentation)

• Market Analysis Countries and Regions: 2000-2010 (With Segmentation)

• Market Forecast Countries and Regions: 2011-2021 (With Segmentation)

Appendix

• Publishing activity by organization (2000-2010)

Table of ExhibitsChapter One

Exhibit 1.1

Formula for the calculation of the Compound Annual Growth Rate (CAGR), (top).

Formula for the calculation of the Compound Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom) [2].

Exhibit 1.2

Formula for the verification of the calculated values of the Compound Annual Growth Rate (CAGR), (top).

Formula for the verification of the calculated values of the Compound Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom) [2].

Exhibit 1.3

Nanometres in a meter (top). Meters in a nanometre (bottom).

Chapter Two

Exhibit 2.1

The periodic table of elements, as we know it (at meter scale) is governed by classic Newtonian laws of physics. However, when perceived at nanoscale, those elements are governed by the laws of quantum physics.

Exhibit 2.2

Proportion of the population aged over 65 and over 80 [7].

Exhibit 2.3

Illustration of a diagram of each property of nanocarriers (size, shape, surface chemistry and mechanical properties) and their parameters subjected to optimization in order to improve their efficiency [10].

Chapter Three

Exhibit 3.1

Specified expected barriers in the development of particular types of nanoparticles (Courtesy of CienNanoroadmap Synthesis Report), [6].

Exhibit 3.2

Illustration of the measures adoption roadmap to combat/attenuate the key barriers to the adoption of nanotechnology in medicine and biomedicine (Source: Cientifica, Ltd.).

Exhibit 3.3

Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.4

Line chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.5

Bar chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.6

Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.7

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.8

Bar chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Chapter Four:

Exhibit 4.8

Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, all countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.9

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures in percentage).

Exhibit 4.10

Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.11

Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.12

3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.13

3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.14

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, all world regions and countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.15

Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, all world regions and countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.16

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures in percentage)

Exhibit 4.17

Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.18

Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.19

3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.20

3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.21

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.22

Horizontal bar graph representing the Total Addressable Market, TAM In 2010, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.23

Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.24

3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.25

3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.46

Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions / countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.47

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures in percentage).

Exhibit 4.48

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.49

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.50

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.51

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.52

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.53

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.54

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.55

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.56

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit4.57

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.58

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.59

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.60

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.61

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.62

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.63

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.64

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.65

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.66

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Appendix

Exhibit A.1

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: North America; country: USA.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.2

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: Germany.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.3

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: France.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.4

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: UK.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.5

Table of publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Country: Russian Federation.

Organizations are ordered alphabetically (increasing order).

Exhibit A.6

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.7

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.8

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: Japan.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.9

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: P R China.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.10

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: South Korea (Republic of Korea).

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.11

Table of publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Asia; country: Taiwan.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

To order this report:Drug Delivery Technology Industry: Nanotechnology in Drug Delivery: Global Markets,

More  

Market Research Report

Check our  

Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

Read more here:
Nanotechnology in Drug Delivery: Global Markets,

The rest is here:
Nanotechnology firm to develop test for handheld biosensors to detect deadly pathogens

www.youtube.com/watch?v=NUMH9abCd7w

Read the original here:
First Review: Nokia HumanForm Nanotechnology – Video

www.youtube.com/watch?v=wwWIb-5tCu0

Follow this link:
3of3 – The Dark Secret of Hendrik Schon – Nanotechnology – Video

www.youtube.com/watch?v=0QMzKF_LqGk

Read the original here:
2of3 – The Dark Secret of Hendrik Schon – Nanotechnology. – Video

www.youtube.com/watch?v=ltLd7L_piEE

Read the original:
Nanotechnology for a Better Future.Part 1 – Mr. J.Akilavasan – SSP2011 – IFSlk – Video

www.youtube.com/watch?v=6xcm8zPgf-I

See more here:
euronews science – Nanotechnology to combat diabetes – Video

See the article here:
Research and Markets: Nanotechnology in Drug Delivery: Global Markets – Nanotech Drug Delivery Will Be 15% of Global …

January 27, 2012

The National Research Council said on Wednesday that in order
to study the potential health hazards of nanotechnology,
researchers will need to drum up an additional $24 million a
year.

The research council said in a study that a new federal
oversight agency is also required to integrate research by
private business, universities and international groups.

Nanotechnology is being used in a fast-growing variety of
consumer products, and involves designing and manufacturing
materials on a one-billionth of a meter scale.

The technology is used in areas ranging from stain-resistant
clothing and cosmetics, to food additives.

The study said that nanotechnology’s product sales were about
$225 billion in 2009 and it is expected to grow rapidly in
the next decade.

“Despite the promise of nanotechnology, without strategic
research into emergent risks associated with it — and a clear
understanding of how to manage and avoid potential risks —
the future of safe and sustainable nanotechnology-based
materials, products, and processes is uncertain,” the study
authors wrote in a statement.

The committee of 19 scientists said little progress has been
made on learning the health effects of engineered
nanotechnology materials (ENMs) that have been swallowed,
inhaled or absorbed by humans.

The federal Centers for Disease Control said there are
indications that nanoparticles are able to penetrate the
skin, or move into the respiratory system.

It said that at this time, limited evidence suggests caution
when being exposed to nanoparticles.

The research council said that half of nanomaterials are made
from ceramic nanoparticles, with another 20 percent each made
from carbon nanotubes and nanoporous materials.

The study said the complexity of ENMs and their coatings make
them hard to determine what risks they are to human health.

It said the federal government set aside $123.5 million in
its 2012 budget for ENM safety research, and that level
should remain stable for about five years.

The committee also said public, private and international
groups should designate another $5 million a year for
collecting and disseminating information on ENM, and $10
million for instrumentation.

Another $3 million to $5 million a year should be invested in
developing and providing benchmark nanomaterials, according
to the report.  Also, another $2 million would be needed
to identify nanomaterials sources and develop research
networks.

The authors said a new body is needed with the authority to
direct federal safety research in place of the existing
National Nanotechnology Initiative.

The study was sponsored by the U.S. Environmental Protection
Agency.

—

On the Net:

Source: RedOrbit Staff & Wire Reports

See original here:
Millions Needed To Ensure Nanotechnology Safety

See more here:
Research and Markets: Nanotechnology in Drug Delivery 2011-2021 Report – Drug Delivery Set to Be One of Highest …

Visit link:
Nanotechnology Safety Strategies Need Improvement

Read the original:
Nanotechnology: Will it kill us all?

Original post:
Research and Markets: Functional Proteomics and Nanotechnology-Based Microarrays 2012 Out Now

Follow this link:
Scienctists Urge More Study of Nanotechnology Risks